GoodRx Holdings

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Various,Pharmaceuticals,Pills,Capsules,Tablets,Softgel,Of,Food,Supplements,,Fish

Analyst Color

News

Health Care

Price Target

Reiteration

Analyst Ratings

Trading Ideas

GDRX

J.P. Morgan analyst revises outlook on GoodRx Holdings following Q1 earnings, reaffirms Overweight rating and $7 price target.

GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst

Modern,Pharmacy,With,Variety,Of,Medications,And,Cosmetics,For,Everyone

Earnings

Guidance

Movers

General

GoodRx reported Q4 revenue of $198.6M, missing expectations. 2025 guidance projects $810M–$840M revenue and adjusted EBITDA of $270M–$286M.

GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales

IMG_5322-1-768x512 copy

Biotech

Large Cap

Eurozone

Novo Nordisk&#39;s Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and cardiovascular risk reduction.

Novo Nordisk&#39;s Ozempic Label Expansion Snags Approval From European Drug Regulator&#39;s Advisory Panel

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings Inc

Press Releases

GoodRx Reports Fourth Quarter and Full Year 2024 Results

GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending

GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement

GoodRx Introduces New E-commerce Experience for Retail Pharmacies

GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call

GoodRx Reports First Quarter 2025 Results

GoodRx to Launch Direct Contracting for Independent Community Pharmacies

GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity

GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing

GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers

Firefly Neuroscience, Inc. - Common Stock

Firefly Neuroscience

American Well Corporation Class A Common Stock

American Well

CareCloud

Certara

Claritev Corporation Class A Common Stock

Claritev

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare

Doximity

DarioHealth

Evolent Health

Forian

Health Catalyst

HealthStream

icad

LifeMD

OptimizeRx

Phreesia

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings

Schrodinger

Simulations Plus

Sophia Genetics

Streamline Health Solutions, Inc. - Common Stock

Streamline Health Solns

TruBridge

Teladoc Health

Veeva Systems

Waystar Holding

Goldman Sachs

Wells Fargo

Truist Securities

Citigroup

Comments

GoodRx Holdings

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell